Clinical Trial Update: Study of Clonidine Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease: [Phase 2]

View source ↗

Summary

Phase 2 study evaluating clonidine for impulse control disorders in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impulse Control Disorders
• Parkinson Disease

Drugs mentioned

• Clonidine (clonidine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Parkinson's Disease, Mpulse Control Disorders | Phase 2 | Status: COMPLETED